Essential, defensive sector with steady demand; growth driven by aging population, rising incomes, and lifestyle changes. Pharma adds strong export potential with regulated returns and R&D focus.
Total Companies 11
Performance -8.7%
Showing 11 out of 11 Companies
| Company | Market cap (₹) | % Change | Revenue YoY (%) | PAT (₹) | IPO Status |
|---|---|---|---|---|---|
S3V Vascular Technologies | 0.00 | 11.0% | 0.00 | 0.00 | Unknown |
Lakeshore Hospital and Research Centre | 1,110.00 | 4.7% | 3.19 | 39.12 | PRE IPO |
Martin and Harris Laboratories | 337.27 | 0.1% | -21.29 | 40.43 | Unknown |
Veeda Clinical Research | 2,933.68 | 1.3% | 52.24 | -66.80 | Unknown |
Down Town Hospital | 1,104.45 | 2.7% | -9.52 | 5.83 | Unknown |
API Holdings (Pharmeasy) | 3,421.25 | 18.6% | 3.84 | -1,593.19 | PRE IPO |
Gynofem Healthcare and Pharmaceutical | 436.54 | 28.5% | 133.33 | -2.09 | Unknown |
Arch Pharmalabs | 1,283.14 | 33.9% | 135.19 | 122.11 | Unknown |
Deys Medical Stores | 0.09 | 0.0% | -1.40 | 4.14 | Unknown |
East India Pharmaceutical Works | 0.67 | 0.0% | 8.76 | 2.21 | Unknown |
Maverick Simulation Solutions | 0.00 | 0.0% | 0.00 | 0.00 | PRE IPO |
MCAP 0.0 Cr.
